These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33051879)

  • 21. Congenital autosomal dominant distal spinal muscular atrophy.
    Adams C; Suchowersky O; Lowry RB
    Neuromuscul Disord; 1998 Aug; 8(6):405-8. PubMed ID: 9713859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw.
    Spiegler AW; Hausmanowa-Pertrusewicz I; Borkowska J; Kłopocka A
    Hum Genet; 1990 Jul; 85(2):211-4. PubMed ID: 2370051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage analysis of spinal muscular atrophy.
    Daniels RJ; Thomas NH; MacKinnon RN; Lehner T; Ott J; Flint TJ; Dubowitz V; Ignatius J; Donner M; Zerres K
    Genomics; 1992 Feb; 12(2):335-9. PubMed ID: 1346777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy.
    Gilliam TC; Brzustowicz LM; Castilla LH; Lehner T; Penchaszadeh GK; Daniels RJ; Byth BC; Knowles J; Hislop JE; Shapira Y
    Nature; 1990 Jun; 345(6278):823-5. PubMed ID: 1972783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human leukocyte antigens in children with spinal muscular atrophy].
    Májský A; Süssová J; Nevsímal O
    Cesk Neurol Neurochir; 1987 Sep; 50(5):304-9. PubMed ID: 3664731
    [No Abstract]   [Full Text] [Related]  

  • 27. [Familial polymorphism of spinal amyotrophy in childhood].
    Badalian LO; Temin PA; Arkhipov BA; Zavadenko NN; Bulaeva NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(11):123-6. PubMed ID: 2624041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal prediction of spinal muscular atrophy.
    Daniels RJ; Suthers GK; Morrison KE; Thomas NH; Francis MJ; Mathew CG; Loughlin S; Heiberg A; Wood D; Dubowitz V
    J Med Genet; 1992 Mar; 29(3):165-70. PubMed ID: 1348091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximal and distal spinal muscular atrophy in one family: molecular genetic studies provide further evidence for the non-allelic origin of both diseases.
    Spranger S; Rudnik-Schöneborn S; Spranger M; Schächtele M; Zerres K; Wirth B
    J Med Genet; 1997 Apr; 34(4):340-2. PubMed ID: 9138162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for compound heterozygosity causing mild and severe forms of autosomal recessive spinal muscular atrophy.
    Talbot K; Rodrigues N; Bernert G; Bittner R; Davies K
    J Med Genet; 1996 Dec; 33(12):1019-21. PubMed ID: 9004135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spinal muscular atrophy: disappearance of RNA fluorescence of degenerating motor neurons. An acridine orange study].
    Sarnat HB; Jacob P; Jiménez C
    Rev Neurol (Paris); 1989; 145(4):305-11. PubMed ID: 2471992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination molecular therapies for spinal muscular atrophy: How much is enough?
    Mathews KD; Iannaccone ST
    Muscle Nerve; 2021 Mar; 63(3):279-281. PubMed ID: 33118639
    [No Abstract]   [Full Text] [Related]  

  • 34. Spinal and bulbar muscular atrophy without tongue atrophy.
    Sugawara M; Kato K; Watanabe S; Toyoshima I
    Eur Neurol; 2001; 45(3):185-6. PubMed ID: 11306865
    [No Abstract]   [Full Text] [Related]  

  • 35. [Spinal muscular atrophy].
    Porro G; Carboni P
    Riv Neurol; 1988; 58(2):45-9. PubMed ID: 3051286
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene-Targeted Therapies and Palliative Care in Children with Spinal Muscular Atrophy Type I: No Intrinsic Contradiction.
    von der Hagen M; Nolte-Buchholtz S; Janisch M; Pietz J; Blankenburg M; Ziegler A
    J Palliat Med; 2021 Feb; 24(2):162-163. PubMed ID: 33522861
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene therapy for spinal muscular atrophy: hope and caution.
    Goemans N
    Lancet Neurol; 2021 Apr; 20(4):251-252. PubMed ID: 33743228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beyond type I spinal atrophy].
    Mastella C
    Assist Inferm Ric; 1999; 18(4):240-6. PubMed ID: 10833298
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of spinal muscular atrophy-like patients by targeted resequencing.
    Hosokawa S; Kubo Y; Arakawa R; Takashima H; Saito K
    Brain Dev; 2020 Feb; 42(2):148-156. PubMed ID: 31734026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].
    Spiegel R; Hagmann A; Boltshauser E; Moser H
    Schweiz Med Wochenschr; 1996 May; 126(21):907-14. PubMed ID: 8693311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.